Rafaela Oliveira

  • Cancer therapeutics
  • Melanoma
  • Polygenic Risk Scores
  • Cancer Genomics
  • Cancer Therapeutics
  • Colorectal Cancer

Rafaela Oliveira completed her BSc in Biochemistry in 2019 and her MSc in Molecular Genetics in 2022, both at the University of Minho. During her bachelor project, supervised by Dr. Maria João Sousa (Department of Biology, UM), she evaluated the possible application of Torulaspora delbrueckii in bread and wine fermentation. Then, during her Master’s thesis, she evaluated the antitumor capacity of Portuguese propolis against BRAF-mutated melanoma cell lines. This work was performed under the supervision of Dr. Fátima Baltazar (ICVS, UM) and Dr. Cristina Aguiar (Department of Biology, UM). For six months (July 2022 – December 2022), she was a volunteer researcher at ICVS, being involved in the project: “Deciphering the role of the serine protease inhibitor SPINT2 managing melanoma tumorigenesis and therapeutic response” (Supervisor: Marta Viana-Pereira). Currently, she is an Affiliated Researcher at ICVS working on the grant project “Evaluation of Polygenic Risk Score in Colorectal Cancer Patients: A Genome-Wide Association Study” (Bolsa Liga Portuguesa Contra o Cancro – NRN 2023), supervised by Dr. Rui M. Reis. Her scientific interest is mainly related to cancer biomarkers, polygenic risk scores, and genetic variations, such as SNPs.

Rafaela Oliveira

  • Cancer therapeutics
  • Melanoma
  • Polygenic Risk Scores
  • Cancer Genomics
  • Cancer Therapeutics
  • Colorectal Cancer

Rafaela Oliveira completed her BSc in Biochemistry in 2019 and her MSc in Molecular Genetics in 2022, both at the University of Minho. During her bachelor project, supervised by Dr. Maria João Sousa (Department of Biology, UM), she evaluated the possible application of Torulaspora delbrueckii in bread and wine fermentation. Then, during her Master’s thesis, she evaluated the antitumor capacity of Portuguese propolis against BRAF-mutated melanoma cell lines. This work was performed under the supervision of Dr. Fátima Baltazar (ICVS, UM) and Dr. Cristina Aguiar (Department of Biology, UM). For six months (July 2022 – December 2022), she was a volunteer researcher at ICVS, being involved in the project: “Deciphering the role of the serine protease inhibitor SPINT2 managing melanoma tumorigenesis and therapeutic response” (Supervisor: Marta Viana-Pereira). Currently, she is an Affiliated Researcher at ICVS working on the grant project “Evaluation of Polygenic Risk Score in Colorectal Cancer Patients: A Genome-Wide Association Study” (Bolsa Liga Portuguesa Contra o Cancro – NRN 2023), supervised by Dr. Rui M. Reis. Her scientific interest is mainly related to cancer biomarkers, polygenic risk scores, and genetic variations, such as SNPs.

Scientific Highlights

1- Oliveira, R. D., Celeiro, S. P., Barbosa-matos, C., Freitas, A. S., Cardoso, S. M., Viana-pereira, M., Almeida- aguiar, C., & Baltazar, F. (2022). Portuguese Propolis Antitumoral Activity in Melanoma Involves ROS Production and Induction of Apoptosis. Molecules, 27, 3533.

2- 2- Araújo C#, Oliveira RD#, Pinto-Ribeiro F, Almeida-Aguiar C. An Insight on the Biomedical Potential of Portuguese Propolis from Gerês. Foods. 2022; 11(21):3431. https://doi.org/10.3390/foods11213431 (# Equal Contribution)

3 – Caetano, A.R.; Oliveira, R.D.; Celeiro, S.P.; Freitas, A.S.; Cardoso, S.M.; Gonçalves, M.S.T.; Baltazar, F.; Almeida-Aguiar, C. Phenolic Compounds Contribution to Portuguese Propolis An–Melanoma Activity. Molecules 2023, 28, 3107. https://doi.org/10.3390/molecules28073107

4 – Caetano, A.R.#; Oliveira, R.D.#; Pereira, R.F.C.; Cardoso, T.V.; Cardoso, A.; Almeida-Aguiar, C. Examination of Raw Samples and Ethanol Extracts of Gerês Propolis Collected in Different Years. Plants 2023, 12, 3909.
https://doi.org/10.3390/plants12223909 (#Equal Contribution)

Add Your Heading Text Here